Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| William J. Weber | CLDI Calidi Biotherapeutics, Inc. | 13G/A | 1% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | TPST Tempest Therapeutics, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Lincoln Park Capital Fund, LLC | ENSC Ensysce Biosciences, Inc. | 13G/A | 3.79% | Dec 31, 2023 | 2y |
| Fourthstone LLC | FNRN First Northern Community Bancorp | 13G | 6.29% | Dec 31, 2023 | 2y |
| Lighthouse Investment Partners, LLC | FRLA Fortune Rise Acquisition Corporation Class A Common Stock | 13G | 5.19% | Dec 31, 2023 | 2y |
| Empyrean Capital Partners, LP | CCVI Churchill Capital Corp VI | 13G/A | 0% | Dec 31, 2023 | 2y |
| DISCIPLINED GROWTH INVESTORS INC /MN | GEOS Geospace Technologies Corp | 13G/A | 11.19% | Dec 31, 2023 | 2y |
| Hillhouse Investment Management, Ltd. | GOSS Gossamer Bio, Inc. | 13G/A | 2.2% | Dec 31, 2023 | 2y |
| ARMISTICE CAPITAL, LLC | VIVO VivoPower PLC | 13G/A | 4.99% | Dec 31, 2023 | 2y |
| Robert W. Humphreys | DLA Delta Apparel Inc. | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| SoftVest Advisors, LLC | PBT Permian Basin Royalty Trust | 13G/A | 8.9% | Dec 31, 2023 | 2y |
| SNYDER CAPITAL MANAGEMENT L P | OPLN OPENLANE, Inc. | 13G/A | 3.77% | Dec 31, 2023 | 2y |
| ArrowMark Colorado Holdings LLC | ANGI Angi Inc. | 13G | 5.99% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | SBXC SilverBox Corp III | 13G/A | 0% | Dec 31, 2023 | 2y |
| Westchester Capital Management, LLC | ROSS Ross Acquisition Corp II | 13G | 9.82% | Dec 31, 2023 | 2y |
| Fourthstone LLC | ISTR Investar Holding Corp | 13G/A | 9.97% | Dec 31, 2023 | 2y |
| Nantahala Capital Management, LLC | SLNO Soleno Therapeutics Inc | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| PAULSON & CO. INC. | MDGL Madrigal Pharmaceuticals, Inc. | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | SUM Summit Materials, Inc. Class A Common Stock | 13G/A | 7.4% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | ACAD Acadia Pharmaceuticals Inc | 13G | 6.9% | Dec 31, 2023 | 2y |
| RA CAPITAL MANAGEMENT, L.P. | RXST RxSight, Inc. | 13G/A | 9.5% | Dec 31, 2023 | 2y |
| Aman Narang | TOST Toast, Inc. | 13G/A | 5.2% | Dec 31, 2023 | 2y |
| DISCIPLINED GROWTH INVESTORS INC /MN | PRLB Proto Labs Inc | 13G/A | 6.74% | Dec 31, 2023 | 2y |
| Ares Trading SA | VERA Vera Therapeutics, Inc. | 13G/A | 3.6% | Dec 31, 2023 | 2y |
| RTW INVESTMENTS, LP | VCEL Vericel Corp | 13G/A | 6.7% | Dec 31, 2023 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | ALT Altimmune, Inc. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Driehaus Capital Management LLC | AAOI Applied Optoelectronics, Inc. | 13G | 7.78% | Dec 31, 2023 | 2y |
| MASON CAPITAL MANAGEMENT LLC | ATS ATS Corp | 13G | 18.5% | Dec 31, 2023 | 2y |
| GREAT POINT PARTNERS LLC | URGN UroGen Pharma Ltd. | 13G/A | 8.49% | Dec 31, 2023 | 2y |
| Fourthstone LLC | SSBK Southern States Bancshares, Inc. Common | 13G/A | 0% | Dec 31, 2023 | 2y |
| Paradigm Biocapital Advisors LP | AMAM Ambrx Biopharma, Inc. Common Stock | 13G/A | 7.1% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | DUET DUET Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Klaus Schauser | APPF Appfolio Inc | 13G/A | 15.1% | Dec 31, 2023 | 2y |
| Atlas Merchant Capital LLC | DUET DUET Acquisition Corp. Class A Common Stock | 13G/A | 0% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | SYRE Spyre Therapeutics, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Newtyn Management, LLC | BVFL BV Financial, Inc. | 13G | 8.8% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | SIDU Sidus Space Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| FIR TREE CAPITAL MANAGEMENT LP | PFSA Profusa, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Boundary Creek Advisors LP | MATV Mativ Holdings, Inc. | 13G | 7% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | ADOC Edoc Acquisition Corp. Class A Ordinary Share | 13G/A | 6.99% | Dec 31, 2023 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | VSTM Verastem, Inc. | 13G/A | 9.99% | Dec 31, 2023 | 2y |
| Antara Capital LP | KRNL Kernel Group Holdings, Inc. Class A Ordinary Shares | 13G | 7.2% | Dec 31, 2023 | 2y |
| T. Rowe Price Investment Management, Inc. | IR Ingersoll Rand Inc. | 13G/A | 8.3% | Dec 31, 2023 | 2y |
| VIKING GLOBAL INVESTORS LP | PHVS Pharvaris N.V. | 13G/A | 7% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | AEE Ameren Corp | 13G/A | 7% | Dec 31, 2023 | 2y |
| ADW Capital Partners, L.P. | RICK Rci Hospitality Holdings, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| Select Equity Group, L.P. | MIDD MIDDLEBY Corp | 13G/A | 9.2% | Dec 31, 2023 | 2y |
| HGC Investment Management Inc. | ISRLF Israel Acquisitions Corp | 13G | 5.22% | Dec 31, 2023 | 2y |
| Jefferies Financial Group Inc. | HLMN Hillman Solutions Corp. | 13G/A | 5.1% | Dec 31, 2023 | 2y |
| Deer Park Road Management Company, LP | ONIT Onity Group Inc. | 13G/A | 7.53% | Dec 31, 2023 | 2y |